Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLCELLULOSE Cause Product use in unapproved indication? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product use in unapproved indication have been filed in association with METHYLCELLULOSE (CITRUCEL). This represents 13.7% of all adverse event reports for METHYLCELLULOSE.

13
Reports of Product use in unapproved indication with METHYLCELLULOSE
13.7%
of all METHYLCELLULOSE reports
5
Deaths
5
Hospitalizations

How Dangerous Is Product use in unapproved indication From METHYLCELLULOSE?

Of the 13 reports, 5 (38.5%) resulted in death, 5 (38.5%) required hospitalization, and 4 (30.8%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLCELLULOSE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLCELLULOSE Cause?

Off label use (18) Drug ineffective (16) Incorrect product administration duration (14) Product complaint (13) Diabetes mellitus (11) Dyspnoea (11) Rectal haemorrhage (11) Constipation (10) Abdominal pain (9) Choking (9)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Related Pages

METHYLCELLULOSE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication METHYLCELLULOSE Demographics